Loading clinical trials...

Evaluation of the VEGA Knee System® Range of Motion | Clinical Trials | Clareo Health

TERMINATEDNCT01768871

Evaluation of the VEGA Knee System® Range of Motion

The primary objective of this study is to evaluate the function of the knee after a total knee replacement with the VEGA system®.

Lead sponsor: Aesculap Implant Systems•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusTERMINATED

Phase—

Enrollment7

Start dateJan 2013

Last updatedNov 14, 2018

Condition

Patients With Total Knee Arthroplasty Using the VEGA System

Locations shown

Rose Medical Center

Denver, Colorado

DBA Hussamy Sports and Hand Center

Vero Beach, Florida

Charles J DePaolo, MD, PA

Asheville, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 14, 2018Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions